BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BNTX BioNTech SE

休市中 10-16 16:00:00 EDT

87.71

-2.49

-2.76%

盘后87.95

+0.24+0.27%

19:44 EDT

最高90.14	最低87.36	成交量110.42万
今开90.14	昨收90.20	日振幅3.08%
总市值220.33亿	流通市值95.60亿	总股本2.51亿
成交额9,727万	换手率1.01%	流通股本1.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BNTX","market":"US","secType":"STK","nameCN":"BioNTech SE","latestPrice":87.71,"timestamp":1792180800000,"preClose":90.2,"halted":0,"volume":1104239,"hourTrading":{"tag":"盘后","latestPrice":87.95,"preClose":87.71,"latestTime":"19:44 EDT","volume":21674,"amount":1901099.0267,"timestamp":1792194273162,"change":0.24,"changeRate":0.002736,"amplitude":0.002736},"delay":0,"changeRate":-0.02760532150776063,"floatShares":109000000,"shares":251204366,"eps":-7.772625,"marketStatus":"休市中","change":-2.49,"latestTime":"10-16 16:00:00 EDT","open":90.14,"high":90.14,"low":87.36,"amount":97273330.02837,"amplitude":0.03082,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.772625,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1570680000000,"exchange":"NASDAQ","adjPreClose":90.2,"preHourTrading":{"tag":"盘前","latestPrice":90.21,"preClose":90.2,"latestTime":"09:29 EDT","volume":3087,"amount":280282.22019,"timestamp":1792157346083,"change":0.01,"changeRate":0.000111,"amplitude":0.041796},"postHourTrading":{"tag":"盘后","latestPrice":87.95,"preClose":87.71,"latestTime":"19:44 EDT","volume":21674,"amount":1901099.0267,"timestamp":1792194273162,"change":0.24,"changeRate":0.002736,"amplitude":0.002736},"volumeRatio":0.8167676842739422,"impliedVol":0.5833,"impliedVolPercentile":0.9761},"requestUrl":"/m/hq/s/BNTX","defaultTab":"news","newsList":[{"id":"2674896322","title":"前BioNTech高管带队，Bambusa Therapeutics(BBTX.US)冲刺纳斯达克，为湿疹药物试验“输血”","url":"https://stock-news.laohu8.com/highlight/detail?id=2674896322","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674896322?lang=zh_cn&edition=full","pubTime":"2026-10-10 14:05","pubTimestamp":1791612349,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Bambusa Therapeutics Inc.已提交首次公开募股申请，计划募集资金，用于开发湿疹及其他炎症性疾病治疗药物的临床试验。文件显示，联合创始人Shanshan Xu曾是BioNTech高管，实益持有Bambusa 21.5%的股份。截至6月底，Bambusa拥有7150万美元现金及等价物。Bambusa预计其股票将在纳斯达克全球精选市场交易，股票代码为BBTX。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4551","BK4588","BNTX","BK4535","BK4568","BK4585","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158673114","title":"美股生物疫苗概念股盘中集体上扬，俄罗斯“不明原因肺炎”病例持续引发关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1158673114","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158673114?lang=zh_cn&edition=full","pubTime":"2026-10-09 21:59","pubTimestamp":1791554397,"startTime":"0","endTime":"0","summary":"10月9日，美股$生物(000504)$疫苗概念股盘中集体上扬，$诺瓦瓦克斯医药(NVAX)$涨超12%，$Moderna(MRNA)$涨超8%，$BioNTech SE(BNTX)$、Vaxcyte涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4551","BK4534","BK4139","BK4547","BNTX","MRNX","NVAX","159657","BK4585","BK4501","LGHT","BK4532","GNOM","WDNA","MRNA","BK4535","BK4533","BK4568","BK4588","IDNA","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671262617","title":"辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝","url":"https://stock-news.laohu8.com/highlight/detail?id=2671262617","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671262617?lang=zh_cn&edition=full","pubTime":"2026-09-29 10:28","pubTimestamp":1790648936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0225284248.USD","SG9999013999.USD","MRNX","IE00BLSP4239.USD","LU0170899867.USD","SGXZ57979304.SGD","LGHT","BK4532","BK4568","LU0289739699.SGD","LU0985481810.HKD","BNTX","SG9999001176.SGD","BK4581","OZEM","LU0225771236.USD","MRNA","LU0122379950.USD","LU1894683348.USD","SG9999002232.USD","LU1883839398.USD","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4535","LU2596442595.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","BK4551","LU0234572021.USD","LU1023059063.AUD","BK4533","BK4534","IDNA","LU0306807586.USD","MRNY","SG9999001176.USD","SG9999002224.SGD","SG9999003800.SGD","LU1066051498.USD","LU1894683264.USD","BK4501","IE0002270589.USD","BK4599","IE00BLSP4452.SGD","BK4588","IE00BBT3K403.USD","LU0306806265.USD","IE00B3T34201.USD","LU0058720904.USD","LU0321505868.SGD","IE00B19Z3581.USD","LU1057294990.SGD","GNOM","LU1066053197.SGD","WDNA","BK4550","BK4592","0P6S.UK","BK4585","BK4139","BK4548","PFE","BK5011","LU0868494617.USD","BK4007","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668901099","title":"ARISTA网络：大股东Andreas Bechtolsheim拟出售30万股，市值约5985.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668901099","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668901099?lang=zh_cn&edition=full","pubTime":"2026-09-18 06:38","pubTimestamp":1789684680,"startTime":"0","endTime":"0","summary":"南财智讯9月18日电，ARISTA网络（AristaNetworks,Inc.，纽约证券交易所：ANET）10%股东AndreasBechtolsheim提交Form144限制股出售声明。AndreasBechtolsheim拟出售30万股普通股，合计市值约5985.90万美元，拟出售日期为9月17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609183877710385.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609183877710385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4548","BNTX","BK4568","BK4588","BK4139","BK4551","BK4585","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141268762","title":"异动解读｜BioNTech盘前上涨超5%，肺癌候选药三期试验总生存期数据积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1141268762","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141268762?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:06","pubTimestamp":1789384003,"startTime":"0","endTime":"0","summary":"9月14日，BioNTech盘前上涨5.04%，报101.23美元/股，成交额116.56万美元。消息面上，BioNTech与OncoC4联合公布了PRESERVE-003三期临床试验第一阶段的更新数据，结果显示候选药物gotistobart在肺癌患者中展现出具有统计学意义的总生存期获益，生存期几乎翻倍。这一积极数据为BioNTech向肿瘤学领域转型提供了关键支撑。值得注意的是，BioNTech此前曾因终止结直肠癌二期试验导致股价大幅下挫，且二季度财报营收和盈利均不及预期，全年收入指引也遭下调。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioNTech盘前上涨，肺癌候选药生存期数据积极","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667570696","title":"生存期几乎翻倍！BioNTech(BNTX.US)肺癌候选药PRESERVE-003后期试验告捷，肿瘤学转型再获关键支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2667570696","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667570696?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:26","pubTimestamp":1789381582,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4551","BK4568","CANC","BK4535","BK4588","BNTX","BK4548","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667064657","title":"生存期几乎翻倍！BioNTech(BNTX.US)肺癌候选药PRESERVE-003后期试验告捷，肿瘤学转型再获关键支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2667064657","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667064657?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:26","pubTimestamp":1789381582,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，BioNTech周一表示，一项后期临床试验显示，其候选药物gotistobart在一种特定类型肺癌中，较标准治疗带来具有临床意义的总生存期获益。公司称，该试验为PRESERVE-003 III期临床试验，纳入的是在接受既往免疫治疗和化疗后疾病仍出现进展的鳞状非小细胞肺癌患者;与标准治疗化疗相比，gotistobart使生存期几乎翻倍。鳞状非小细胞肺癌约占所有肺癌病例的25%至30%，在非小细胞肺癌中属于侵袭性较强的亚型。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4551","BK4535","BK4548","BNTX","BK4588","BK4568","CANC","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192361867","title":"异动解读｜BioNTech盘中下跌5.08%，遭BMO下调评级至与大市同步","url":"https://stock-news.laohu8.com/highlight/detail?id=1192361867","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192361867?lang=zh_cn&edition=full","pubTime":"2026-09-08 23:37","pubTimestamp":1788881832,"startTime":"0","endTime":"0","summary":"9月8日，BioNTech盘中下跌5.08%，报98.485美元/股，成交额4746.28万美元。消息面上，BMO Capital Markets将BioNTech评级从\"跑赢大市\"下调至\"与大市同步\"，目标价由128美元下调至105美元，理由是近期上行空间有限、风险回报趋于平衡。BioNTech SE成立于2008年，专注于结合免疫学研究与mRNA等治疗平台，开发针对癌症和其他疾病的个体化免疫疗法。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioNTech遭下调评级，股价承压下探","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100460280","title":"美股生物医药股盘初走低，BioNTech跌超9%、Moderna跌近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100460280","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100460280?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:37","pubTimestamp":1787924271,"startTime":"0","endTime":"0","summary":"8月28日，美股生物医药股盘初走低，$BioNTech(BNTX)$跌超9%，公司宣布终止结直肠癌2期临床试验；$Moderna(MRNA)$跌近5%，$默沙东(MRK)$跌1.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU0006306889.USD","LU2089984988.USD","IE0002141913.USD","IE00BN8TJ469.HKD","SG9999015358.SGD","LU0859254822.USD","SG9999014559.SGD","BK4548","LU1974910355.USD","LU2491049909.HKD","LU0289739699.SGD","LU1066051225.USD","BMED","IE00BJJMRZ35.SGD","LU1430594728.SGD","BNTX","LU2491050071.SGD","IBBQ","LU0238689110.USD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","SG9999014567.USD","LU0265550359.USD","MRNY","LU2361044949.HKD","GDOC","SGXZ57979304.SGD","BK4532","LU0965509010.AUD","IHE","LU0823416689.USD","LU1941712348.USD","IE00BLSP4239.USD","BK4007","LU1057294990.SGD","LU0122379950.USD","BK4533","LU2023250504.SGD","LU1934455863.HKD","XBI","LU0965508806.USD","FTXH","FHLC","LU2125154778.USD","LU2360032135.SGD","SG9999015341.SGD","IE000M9KFDE8.USD","PPH","LU1066051811.HKD","BK4516","LU0320765646.SGD","LU1066051498.USD","LU2106854487.HKD","LU0124676726.USD","GNOM","LU1093756168.USD","LU1934455277.USD","LU2461242641.AUD","BK4559","IE00B2B36J28.USD","LU2361045086.USD","IBBJ","LU2361044865.SGD","LU0942090050.USD","IE00BSNM7G36.USD","LU1162221912.USD","LU1934455194.USD","LU2023250843.SGD","BK4551","LU1571399168.USD","LU0648001328.SGD","IE00B1BXHZ80.USD","LU1989772840.SGD","LU1917777945.USD","IXJ","LU1116320737.USD","LU0965509283.SGD","IE00BBT3K403.USD","LU1201861249.SGD","LU2112291526.USD","BK4588","LU0965509101.SGD","MRNA","XLV","LU0265550946.USD","LU1061106388.HKD","HRTS","LU1699723380.USD","TRUH","BK4139","RXL","161726","LU0208291251.USD","LU1066053197.SGD","LU0868494708.USD","LU1069347547.HKD","LU2125154935.USD","LU0266013472.USD","LU1989771016.USD","SG9999002232.USD","MDTX","BK4550","LU1023059063.AUD","MRK","LU2468319806.SGD","LU2491050154.USD","LU0203345920.USD","LU2125909247.SGD","LU1037948897.HKD","PSYK","LU0130517989.USD","SG9999013999.USD","LU1929549753.HKD","LU0320765489.SGD","LU0861579265.USD","LU1585245621.USD","LU0868494617.USD","LU0098860793.USD","IE00B4R5TH58.HKD","MRNX","LU1116320901.HKD","LU1093756325.SGD","LU1983299246.USD","LU0130102774.USD","LU1941712264.USD","LU2357627491.SGD","LU0203347892.USD","LU1923622614.USD","IE0009355771.USD","SG9999014575.USD","VHT","WDNA","BK4534","LU0106261372.USD","LU0234572021.USD","BK4501","LU0058720904.USD","LU0432979614.USD","JDOC","LU0980610538.SGD","LU2125909593.SGD","LU2324357040.USD","SG9999014542.SGD","LU0477156953.USD","LU2433249047.HKD","SG9999001176.USD","BK4585","IYH","LU0070302665.USD","LU0211331839.USD","LU0985320562.USD","LU1989772923.USD","IE00BJT1NW94.SGD","IDNA","LU1291159041.SGD","BK4581","LU1037948541.HKD","BK4568","LU1035773651.USD","SG9999001440.SGD","PAWZ","SG9999001176.SGD","LU0689626769.HKD","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662096564","title":"美股三大股指涨跌互现，纳指跌 0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662096564","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662096564?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:32","pubTimestamp":1787923979,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Gate 行情数据显示，美股开盘，三大股指涨跌互现，道指涨 0.21%，标普 500 指数涨 0.05%，纳指跌 0.09%。\n\nBioNTech(BNTX.O) 跌约 8.7%，宣布终止结直肠癌 2 期临床试验。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2286268","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","FTEC","PSQ","QQQE","IYW","GPIQ","QDTE","TECS","JEPQ","TQQY",".IXIC","NDX",".HXC","BK4535","QID","ONEQ","BK4568","BK4548","BNTX","MNQmain","QQQM","QQQY","QQQJ","BK4139","BK4588","BK4585","QQQA","QYLG","NVIW.SI","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100503819","title":"异动解读｜BioNTech SE盘中下跌8.22%，终止癌症免疫疗法试验叠加新冠疫苗适用人群收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1100503819","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100503819?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:32","pubTimestamp":1787923929,"startTime":"0","endTime":"0","summary":"8月28日，BioNTech SE盘中下跌8.22%，报99.11美元/股，成交额5648.04万美元。消息面上，公司宣布终止2期Autogene Cevumeran结直肠癌免疫疗法试验，该管线为公司mRNA肿瘤治疗领域的核心项目之一，终止意味着其从新冠疫苗向肿瘤免疫治疗转型的关键布局遭遇重大挫折。与此同时，辉瑞与BioNTech针对XFG变体的新冠疫苗虽获FDA批准，但适用范围仅限65岁及以上成年人和5至64岁高风险人群，较此前面向全人群接种的授权范围显著收窄，市场对其新冠疫苗收入前景进一步承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"BioNTech重挫，终止癌症试验叠加疫苗受限","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199946302","title":"BioNTech SE宣布终止2期Cevumeran癌症免疫疗法试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1199946302","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199946302?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:14","pubTimestamp":1787922863,"startTime":"0","endTime":"0","summary":"8月28日，BioNTech SE盘前暴跌逾14%，公司宣布终止2期Cevumeran癌症免疫疗法试验。","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"BioNTech SE宣布终止2期Cevumeran癌症免疫疗法试验","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119668872","title":"异动解读｜BioNTech盘前下跌11.62%，新冠疫苗获批但适用人群范围大幅收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1119668872","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119668872?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:11","pubTimestamp":1787922698,"startTime":"0","endTime":"0","summary":"8月28日，BioNTech盘前下跌11.62%，报99.36美元/股，成交额252.29万美元。消息面上，辉瑞与BioNTech宣布其针对XFG变体的新冠疫苗获FDA批准，但适用范围仅限65岁及以上成年人以及5至64岁具有高风险基础疾病的人群，相较此前年份面向全人群接种的授权范围显著收窄，市场对其新冠疫苗收入前景进一步承压。受限的获批人群叠加持续恶化的基本面，令投资者信心进一步受挫。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709537","title":"BioNTech SE(BNTX.US)美股盘前跌约10%，公司宣布终止2期Cevumeran癌症免疫疗法试验。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709537","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662709537?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:11","pubTimestamp":1787922662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4568","BK4551","BNTX","BK4548","BK4588","BK4535","BK4139","BK4585","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149097187","title":"异动解读｜BioNTech SE盘中上涨5.69%，mRNA癌症疫苗三期试验成功余热持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1149097187","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149097187?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:04","pubTimestamp":1787321092,"startTime":"0","endTime":"0","summary":"消息面上，Moderna与默沙东联合研发的全球首个mRNA个性化癌症疫苗此前在III期临床试验中取得阳性结果，被视为mRNA技术平台在肿瘤治疗领域的历史性突破。该事件持续提振mRNA板块情绪，同行业Moderna当日仍上涨12.07%。BioNTech作为全球领先的mRNA技术平台公司，市场对其核心技术路线在癌症免疫治疗中的拓展前景持续看好，股价延续强势。BioNTech SE专注于结合免疫学与mRNA等尖端治疗平台，开发针对癌症和其他疾病的个体化免疫疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioNTech盘中大涨，mRNA癌症疫苗热度延续","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194520061","title":"异动解读｜BioNTech SE盘中上涨23.13%，mRNA癌症疫苗三期试验成功提振板块","url":"https://stock-news.laohu8.com/highlight/detail?id=1194520061","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194520061?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:16","pubTimestamp":1787149018,"startTime":"0","endTime":"0","summary":"8月19日，BioNTech SE盘中上涨23.13%，报114.09美元/股，成交额4.27亿美元。消息面上，Moderna与默沙东联合研发的mRNA黑色素瘤癌症疫苗三期临床试验取得成功，被市场视为mRNA技术平台在肿瘤治疗领域的历史性突破。BioNTech作为全球领先的mRNA技术平台公司，该试验成功直接验证了其核心技术路线在癌症免疫治疗中的广阔前景，带动公司股价大幅走高。BioNTech SE成立于2008年，专注于结合免疫学与mRNA等尖端治疗平台，开发针对癌症和其他疾病的个体化免疫疗法。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162002657","title":"美股开盘 | 三大指数高开，Moderna涨超84%，迈威尔科技涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162002657","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162002657?lang=zh_cn&edition=full","pubTime":"2026-08-19 21:30","pubTimestamp":1787146228,"startTime":"0","endTime":"0","summary":"8月19日，美股三大指数集体高开，道琼斯指数涨0.37%，标普500指数涨0.41%，纳斯达克综合指数涨0.36%。Moderna涨超84%，mRNA癌症疫苗三期试验成功，黑色素瘤治疗迎来历史性突破。医药股大涨，BioNTech SE涨超17%，默沙东涨超8%，诺瓦瓦克斯医药涨超6%。SK海力士涨近5%。公司拟回购40万亿韩元并注销。迈威尔科技涨超10%。消息面上，公司表示已向谷歌发行最多5897万股认股权证，行权价格设定为每股206.58美元。NEBIUS跌超6%，公司拟发行45亿美元可转换优先票据。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2092937148.SGD","SG9999014567.USD","NBIZ","IE00BJJMRZ35.SGD","LU1316542783.SGD","BK4612","VOX","LU0203345920.USD","SKHZ","LU2764263039.SGD","LU0170899867.USD","BK4515","LU1127390331.HKD","LU1803068979.SGD","IDNA","GOOG","BK4568","IE000M9KFDE8.USD","SGOOGmain","BK4534","LU0006306889.USD","LU1119994496.HKD","LU0308772762.SGD","MRVU","PPH","SGXZ31699556.SGD","BK4550","LU2324357040.USD","FTXH","SKHA","LU2108987350.USD","SDOW","SMHX","FAI","BK4533","IE0004086264.USD","LU1917777945.USD","LU0070302665.USD","BK4527","LU1861215975.USD","LU0289941410.SGD","LU1037948541.HKD","BK4139","IE0009355771.USD","LU0859254822.USD","LU1642822529.SGD","GOOP","LU0053666078.USD","IE00B2B36J28.USD","SG9999001176.SGD","LU1839511570.USD","SKHU","LU0323591593.USD","LU0122379950.USD","LU0642271901.SGD","MVLL","LU1983299246.USD","DDM","IE00B1BXHZ80.USD","LU0234572021.USD","LU2452424414.USD","IE00BK4W5L77.USD","LU1989772923.USD","LU1057294990.SGD","LU1169589451.USD","USJW.SI","QQQA","LU0072461881.USD","SNPE","LU2087621335.USD","LU0082616367.USD","IE00BJLML261.HKD","GXPC","AIS","LU2461242641.AUD","LU1992135472.HKD","BK4097","LU0648001328.SGD","LU2764263203.CNY","SG9999001440.SGD","BK4604","LU2637965513.SGD","LU0210528500.USD","AIFD","LU0266013472.USD","SG9999015978.USD","BK4587","DXD","BK4547","LU0098860793.USD","LU2237443549.SGD","LU1852331112.SGD","IE00BLSP4239.USD","BK4579","BK4525","LU1992135399.USD","EFIV","UDOW","LU1778281490.HKD","IE00BWXC8680.SGD","BK4553","LU1691799644.USD","JGRO","LU0689626769.HKD","LU1235294995.USD","LU1914381329.SGD","XLC","LU1974910355.USD","LU1989772840.SGD","IE000MB6IJN5.SGD","LU1201861249.SGD","LU1066051498.USD","LU0133085943.USD","MRK","LU0444973449.USD","SKUU","LU2098885051.SGD","LU0079474960.USD","LU2272731865.HKD","FXL","SG9999002224.SGD","SG9999018865.SGD","IE000F7OJYX1.SGD","IE0005OL40V9.USD","BK4532","SG9999001176.USD","BK4605","LTL","TRUC","LU1934455863.HKD","FHLC","LU1261432733.SGD","LU0444971666.USD","SG9999015341.SGD","SGXZ80539844.SGD","LU1861220033.SGD","LU1548497426.USD","IE00B4R5TH58.HKD","LU2133065610.SGD","LU1066051811.HKD","IE00BJJMRY28.SGD","LU2322448957.HKD","SG9999001077.SGD","IE00B3S45H60.SGD","IE00BN8TJ469.HKD","IE00BMPRXR70.SGD","LU2458330169.SGD","BK4501","IE00B5949003.HKD","LU0058720904.USD","IE00B1XK9C88.USD","LU0868494617.USD","BK4581","LU1066051225.USD","SKDD","LU2290526834.HKD",".DJI","LU1989764664.SGD","LGHT","LU2361045086.USD","LU1989764748.USD","RXL","XLV","SG9999014880.SGD","BK4566","IE00BYQQ9H92.USD","LU0211331839.USD","LU2360107168.USD","LU1585245621.USD","BK4559","LU0061475181.USD","LU0432979614.USD","SG9999017495.SGD","LU0466842654.USD","BK4077","BK4588","LU2552382058.USD","LU2237443895.HKD","IE00B775SV38.USD","HYNX","CNEQ","IE00BFXG0V08.USD","LU2125154935.USD","LU0640476718.USD","SG9999018857.SGD","LU2125909593.SGD","LU2552382215.SGD","SOXY","LU0203202063.USD","IE00BKDWB100.SGD","LU0965509101.SGD","LU0950373646.USD","IE00BZ199S13.USD","LU2473716301.USD","BK4548","IE00B4JS1V06.HKD","LU1084165304.USD","IE0002141913.USD","BK4007","SG9999015945.SGD","LU2023250843.SGD","LU0823434583.USD","NBIS","LU0265550946.USD","BK4609","SG9999015358.SGD","LU0786609619.USD","ARTY","LU2089984988.USD","NBIG","IE00BBT3K403.USD","LU1989771016.USD","LU1303367103.USD","LU1430594728.SGD","LU2023250504.SGD","NVAX","LU1934455277.USD","LU2552382132.HKD","IE0034235303.USD","LU0942090050.USD","LU1979441026.SGD","LU0965509283.SGD","LU1674673428.USD","LU2931357623.SGD","MRNY","LU1035775433.USD","LU0980610538.SGD","IE00BJJMRX11.SGD","SG9999014542.SGD","HRTS","LU0320765646.SGD","IXJ","IHE","LU0823434740.USD","YMmain","IE000WAW04H5.SGD","LU0965508806.USD","LU1093756325.SGD","LU1815336760.USD","GDOC","LU2491049909.HKD","JDOC","LU2092627202.USD","LU2237443465.HKD","LU2112291526.USD","LU1069344957.HKD","LU1699723380.USD","IE00B775H168.HKD","LU0823421416.USD","LU0476273544.USD","LU1804176565.USD","LU0106261372.USD","LU0124676726.USD","LU0238689110.USD","LU0127658192.USD","LU0878866978.SGD","IE00BJT1NW94.SGD","LU1923622614.USD","LU2468319806.SGD","BNTX","LU2360032135.SGD","LU1571399168.USD","LU0289739699.SGD","FTXL","LU0208291251.USD","LU2720916845.USD","IYH","LU0531971165.HKD","LU0868494708.USD","LU0433182093.SGD","LU0234570918.USD","LU0719512351.SGD","LU0081259029.USD","LU0861579265.USD","SGXZ57979304.SGD","LU1116320737.USD","SG9999014914.USD","BK4514","VHT","LU0329931090.USD","IE000BZT7R73.USD","BK4535","LU0109392836.USD","LU1023059063.AUD","LU0889565833.HKD","LU2106854487.HKD","SG9999002232.USD","LU1941712264.USD","SG9999014898.SGD","SKHX","BMED","FCOM","LU0068578508.USD","LU2491050071.SGD","SG9999013999.USD","LU2237443382.USD","LU2896262040.SGD","LU1674673691.USD","LU0056508442.USD","LU0823431563.USD","LU0154236417.USD","LU1037948897.HKD","LU0348723411.USD","DTCR","LU0320765489.SGD","LU0456855351.SGD","SG9999014906.USD","SG9999000418.SGD","LU0965509010.AUD","LU2361044949.HKD","IE0009356076.USD","LU0072462426.USD","WDNA","IE00BFTCPJ56.SGD","IE0004091025.USD","MRVL","LU1934455194.USD","PAWZ","LU2491050154.USD","LU0175139822.USD","GNOM","LU1720051017.SGD","LU2272731782.SGD","LU2247934214.USD","IE00BMPRXQ63.HKD","LU1069347547.HKD","NEBX","LU0985489474.SGD","BK4592","LU1066053197.SGD","LU0203201768.USD","LU2361044865.SGD","BK4585","07709","LU0130102774.USD","IE000SO60NU8.SGD","SG9999014575.USD","BK4141","LU1280957306.USD","MRVX","DIA","LU2543165471.USD","LU0724617625.USD","LU0985320562.USD","WUGI","LU1823568750.SGD","LU1489326972.SGD","TRUH","LU0957808578.USD","SKHYV","LU0203347892.USD","BK4543","IE00BK4W5M84.HKD","LU0823431647.USD","LU0210536198.USD","SK","LU0477156953.USD","XNTK","LU0329931173.USD","LU2089985449.USD","SG9999014559.SGD","LU1720051108.HKD","LU2322448791.USD","LU2764262908.HKD","MRNA","FDTX","SG9999015986.USD","LU0265550359.USD","BK4507","LU1116320901.HKD","BK4554","NBIL","LU2487616109.SGD","BK4602","LU1162221912.USD","LU1291159041.SGD","IE00B5TLWC47.USD","LU2125154778.USD","LU2237443978.SGD","LU0788109477.HKD","LU0823416689.USD","GOOX","LU2237443622.USD","IE00BN29S564.USD","IE00BMPRXN33.USD","IE0004445015.USD","BK4516","IE0000B7K699.USD","LU2125909247.SGD","LU1093756168.USD","BK4551","LU1061106388.HKD","LU2602419157.SGD","MRNX","LU0274383776.USD","IE00BSNM7G36.USD","IE0004445239.USD","IE00BFSS7M15.SGD","GTEK","LU1169590202.USD","LU1929549753.HKD","LU2244417387.USD","LU0494093205.USD","LU1814569148.SGD","LU2286300806.USD","LU0130517989.USD","LU2357627491.SGD","IE00BLSP4452.SGD","LU2357305700.SGD","LU1035773651.USD","LU1046421795.USD","LU2077746001.SGD","LU0289960550.SGD","LU2463028550.USD","LU1074936037.SGD","LU0823421333.USD","LU0162691827.USD","LU2272731600.USD","SG9999015952.SGD","IE00B7KXQ091.USD","SKHY","LU0187121727.USD","IE00BFSS8Q28.SGD","DOG","LU2433249047.HKD","LU2265009873.SGD","LU2458330243.SGD","LU1941712348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660942332","title":"生物科技个股盘前大涨，因莫德纳与默沙东联合研发的黑色素瘤疫苗大型临床试验取得成功。拜恩泰科的美股上涨17.4%，诺瓦瓦克","url":"https://stock-news.laohu8.com/highlight/detail?id=2660942332","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660942332?lang=zh_cn&edition=full","pubTime":"2026-08-19 20:32","pubTimestamp":1787142755,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","SG9999014567.USD","HRTS","LU0823416689.USD","SG9999002232.USD","LU1061106388.HKD","LU1934455863.HKD","BNTX","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","LU2112291526.USD","BK4548","LU1430594728.SGD","LU2106854487.HKD","IE00BLSP4239.USD","LU0130517989.USD","IE00B1BXHZ80.USD","PPH","LU1037948897.HKD","LU0234572021.USD","IYH","IE00BFTCPJ56.SGD","LU1917777945.USD","LU0689626769.HKD","IE0009355771.USD","LU0965508806.USD","RXL","SG9999014542.SGD","BK4588","LU0942090050.USD","LU0208291251.USD","LU0432979614.USD","LU2324357040.USD","LU0266013472.USD","LU2089984988.USD","LU2491049909.HKD","LU0203347892.USD","BK4551","LU1162221912.USD","LU1941712264.USD","LU0965509010.AUD","SG9999001440.SGD","LU0211331839.USD","LU2360032135.SGD","SG9999013999.USD","LU0265550359.USD","LU1989771016.USD","IXJ","LU0070302665.USD","LU0320765489.SGD","LU1989772923.USD","LU0477156953.USD","LU1116320737.USD","LU2433249047.HKD","BK4585","SG9999001176.USD","IHE","VHT","LU1934455194.USD","LU1201861249.SGD","LU0238689110.USD","IE00B2B36J28.USD","IE00BBT3K403.USD","LU0980610538.SGD","LU2491050154.USD","LU2125909247.SGD","LU1035773651.USD","LU1983299246.USD","BK4516","LU1974910355.USD","LU1066051498.USD","BK4550","LU2357627491.SGD","LU1057294990.SGD","LU0965509101.SGD","NVAX","LU0868494708.USD","LU0106261372.USD","IE00BN8TJ469.HKD","LU1934455277.USD","LU1116320901.HKD","BK4533","PAWZ","LU1093756325.SGD","LU0203345920.USD","LU1699723380.USD","LU1585245621.USD","LU2361044949.HKD","LU0124676726.USD","LU0868494617.USD","LU0859254822.USD","LU0965509283.SGD","LU0122379950.USD","SG9999001176.SGD","SG9999015358.SGD","SG9999015341.SGD","BK4007","LU1989772840.SGD","LU2468319806.SGD","XLV","LU1037948541.HKD","LU2361044865.SGD","LU1929549753.HKD","IE0002141913.USD","BK4139","BK4547","LU1066051225.USD","IE00BLSP4452.SGD","LU1923622614.USD","FTXH","LU1023059063.AUD","LU0130102774.USD","LU1069347547.HKD","LU2125154778.USD","LU0985320562.USD","LU0861579265.USD","BK4534","LU0006306889.USD","LU1066051811.HKD","LU0058720904.USD","LU2125154935.USD","MRK","IE000M9KFDE8.USD","LU0289739699.SGD","LU2361045086.USD","LU1291159041.SGD","LU1066053197.SGD","LU2461242641.AUD","FHLC","IE00BJT1NW94.SGD","BK4568","LU1093756168.USD","JDOC","SG9999014559.SGD","LU0265550946.USD","LU2491050071.SGD","SG9999002224.SGD","TRUH","BK4535","LU0320765646.SGD","LU2023250843.SGD","BK4559","LU2023250504.SGD","LU0648001328.SGD","LU2125909593.SGD","IE00BSNM7G36.USD","LU0098860793.USD","SG9999014575.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164864661","title":"BioNTech宣布管理层重大变动：Guido Oelkers将于2027年2月1日接任CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1164864661","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164864661?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:06","pubTimestamp":1785841564,"startTime":"0","endTime":"0","summary":"路透社8月4日消息——BioNTech SE 发布第二季度财报，并宣布了一项关键人事任命。公司第二季度营收达到1.056亿欧元，但净亏损高达8.208亿欧元，每股亏损为3.24欧元。与此同时，BioNTech正式任命Guido Oelkers为首席执行官，该任命将于2027年2月1日正式生效。在业务进展方面，BioNTech迎来了利好消息——其针对新变异株的新冠疫苗已获得欧洲委员会批准。这一表态折射出BioNTech对市场动态的审慎态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4535","BNTX","BK4551","BK4585","BK4139","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148180088","title":"异动解读 | 财报显示净亏损超8亿欧元，BioNTech盘前大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148180088","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148180088?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:00","pubTimestamp":1785841253,"startTime":"0","endTime":"0","summary":"BioNTech SE(BNTX)今日盘前大跌5.78%，引起市场广泛关注。消息面上，公司公布的二季度财报显示，净亏损达8.208亿欧元，营收为1.056亿欧元。这一大幅亏损的业绩表现，显著低于市场预期，导致投资者信心受挫，股价承压。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BNTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biontech.com","stockEarnings":[{"period":"1week","weight":-0.0954},{"period":"1month","weight":-0.0847},{"period":"3month","weight":-0.0412},{"period":"6month","weight":-0.1478},{"period":"1year","weight":-0.1653},{"period":"ytd","weight":-0.0787}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioNTech SE成立于2008年6月2日。该公司结合了数十年的免疫学，尖端治疗平台以及各种患者分析和生物信息学工具的开创性研究，开发针对癌症和其他疾病的个体化免疫疗法。该公司利用强大的新治疗机制，利用各种生物学靶点，利用每位患者免疫系统的力量，解决每位患者潜在疾病的独特分子特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.014337},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.037906},{"month":3,"riseRate":0.571429,"avgChangeRate":0.057688},{"month":4,"riseRate":0.428571,"avgChangeRate":0.076942},{"month":5,"riseRate":0.571429,"avgChangeRate":0.029093},{"month":6,"riseRate":0.571429,"avgChangeRate":0.037799},{"month":7,"riseRate":0.857143,"avgChangeRate":0.124155},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.027067},{"month":9,"riseRate":0.285714,"avgChangeRate":0.012911},{"month":10,"riseRate":0.571429,"avgChangeRate":0.004808},{"month":11,"riseRate":0.857143,"avgChangeRate":0.192937},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.033371}],"exchange":"NASDAQ","name":"BioNTech SE","nameEN":"BioNTech SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioNTech SE,BNTX,BioNTech SE股票,BioNTech SE股票老虎,BioNTech SE股票老虎国际,BioNTech SE行情,BioNTech SE股票行情,BioNTech SE股价,BioNTech SE股市,BioNTech SE股票价格,BioNTech SE股票交易,BioNTech SE股票购买,BioNTech SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}